Joel Andrews

1.2k total citations
41 papers, 804 citations indexed

About

Joel Andrews is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Joel Andrews has authored 41 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 17 papers in Oncology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Joel Andrews's work include DNA Repair Mechanisms (14 papers), PARP inhibition in cancer therapy (12 papers) and Phosphodiesterase function and regulation (5 papers). Joel Andrews is often cited by papers focused on DNA Repair Mechanisms (14 papers), PARP inhibition in cancer therapy (12 papers) and Phosphodiesterase function and regulation (5 papers). Joel Andrews collaborates with scholars based in United States, United Kingdom and Netherlands. Joel Andrews's co-authors include Sailen Barik, Robert W. Sobol, Natalie R. Gassman, Alla Musiyenko, Tanmay Majumdar, Jennifer Clark, Samer Swedan, Marie E. Migaud, Christopher A. Koczor and Ajay P. Singh and has published in prestigious journals such as Nature, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Joel Andrews

38 papers receiving 793 citations

Peers

Joel Andrews

ONCOL

EPIDE

IMMUN

Marianna Nicoletta Rossi Italy

Padmaja Gade United States

Anja Stefanski Germany

Michel Roberge Canada

Frédéric Delom France

Shimeng Zhang China

Jay Shankar Canada

Ji-An Pan United States

Adi Naamati United Kingdom

Matthew A. McBrian United States

Marianna Nicoletta Rossi Italy

Joel Andrews

560 ×1.1

258 ×1.1

ONCOL

160 ×1.2

48 ×0.4

EPIDE

216 ×2.0

IMMUN

Citations per year, relative to Joel Andrews Joel Andrews (= 1×) peers Marianna Nicoletta Rossi

Countries citing papers authored by Joel Andrews

Since Specialization

Citations

This map shows the geographic impact of Joel Andrews's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel Andrews with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel Andrews more than expected).

Fields of papers citing papers by Joel Andrews

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel Andrews. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel Andrews. The network helps show where Joel Andrews may publish in the future.

Co-authorship network of co-authors of Joel Andrews

This figure shows the co-authorship network connecting the top 25 collaborators of Joel Andrews. A scholar is included among the top collaborators of Joel Andrews based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel Andrews. Joel Andrews is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Flores, Deolinda, et al.. (2025). Development and characterization of a novel NEIL1 nanobody. DNA repair. 150. 103849–103849.

Roos, Wynand P., Joel Andrews, Zhijin Wu, et al.. (2025). Overexpression of the WWE domain of RNF146 modulates poly-(ADP)-ribose dynamics at sites of DNA damage. DNA repair. 150. 103845–103845. 1 indexed citations

Lin, Mike T., Theodore T. Pierce, Joel Andrews, et al.. (2025). Nerve-to-cancer transfer of mitochondria during cancer metastasis. Nature. 644(8075). 252–262. 13 indexed citations

Roos, Wynand P., Christopher A. Koczor, Joel Andrews, et al.. (2024). Oncometabolite 2-hydroxyglutarate suppresses basal protein levels of DNA polymerase beta that enhances alkylating agent and PARG inhibition induced cytotoxicity. DNA repair. 140. 103700–103700. 4 indexed citations

Rich, Thomas C., et al.. (2023). Algorithm for biological second messenger analysis with dynamic regions of interest. PLoS ONE. 18(5). e0284394–e0284394. 2 indexed citations

Koczor, Christopher A., et al.. (2022). Quantitative Analysis of Nuclear Poly(ADP-Ribose) Dynamics in Response to Laser-Induced DNA Damage. Methods in molecular biology. 2609. 43–59. 5 indexed citations

Gavin, Elaine, Alla Musiyenko, Wito Richter, et al.. (2022). Phosphodiesterase 10A (PDE10A) as a novel target to suppress β-catenin and RAS signaling in epithelial ovarian cancer. Journal of Ovarian Research. 15(1). 120–120. 13 indexed citations

Koczor, Christopher A., Joel Andrews, Jennifer Clark, et al.. (2021). Temporal dynamics of base excision/single-strand break repair protein complex assembly/disassembly are modulated by the PARP/NAD+/SIRT6 axis. Cell Reports. 37(5). 109917–109917. 44 indexed citations

Li, Jianfeng, Md Ibrahim, Xuemei Zeng, et al.. (2021). NAD+ bioavailability mediates PARG inhibition-induced replication arrest, intra S-phase checkpoint and apoptosis in glioma stem cells. NAR Cancer. 3(4). zcab044–zcab044. 18 indexed citations

10.

Wilk, Anna, Faisal Hayat, Richard P. Cunningham, et al.. (2020). Extracellular NAD+ enhances PARP-dependent DNA repair capacity independently of CD73 activity. Scientific Reports. 10(1). 651–651. 67 indexed citations

11.

Clark, Jennifer, et al.. (2020). NAD+-mediated regulation of mammalian base excision repair. DNA repair. 93. 102930–102930. 34 indexed citations

12.

Fang, Qingming, Joel Andrews, Nidhi Sharma, et al.. (2019). Stability and sub-cellular localization of DNA polymerase β is regulated by interactions with NQO1 and XRCC1 in response to oxidative stress. Nucleic Acids Research. 47(12). 6269–6286. 21 indexed citations

13.

Lee, Kevin J., et al.. (2019). Defective base excision repair in the response to DNA damaging agents in triple negative breast cancer. PLoS ONE. 14(10). e0223725–e0223725. 25 indexed citations

14.

Saki, Mohammad, Haruhiko Makino, Prashanthi Javvadi, et al.. (2017). EGFR Mutations Compromise Hypoxia-Associated Radiation Resistance through Impaired Replication Fork–Associated DNA Damage Repair. Molecular Cancer Research. 15(11). 1503–1516. 8 indexed citations

15.

Andrews, Joel, et al.. (2017). Application of Laser Micro-irradiation for Examination of Single and Double Strand Break Repair in Mammalian Cells. Journal of Visualized Experiments. 25 indexed citations

16.

Schmitt, David, Joel Andrews, & Ming Tan. (2016). Determination of Breast Cancer Cell Migratory Ability. Methods in molecular biology. 1406. 171–180. 6 indexed citations

17.

Braganza, Andrea, Jianfeng Li, Xuemei Zeng, et al.. (2016). UBE3B Is a Calmodulin-regulated, Mitochondrion-associated E3 Ubiquitin Ligase. Journal of Biological Chemistry. 292(6). 2470–2484. 33 indexed citations

18.

Schmitt, David, Luciana Madeira da Silva, R Arora, et al.. (2015). ErbB2-intronic MicroRNA-4728: a novel tumor suppressor and antagonist of oncogenic MAPK signaling. Cell Death and Disease. 6(5). e1742–e1742. 30 indexed citations

19.

Srivastava, Sanjeev K., Arun Bhardwaj, Sumit Arora, et al.. (2015). MicroRNA-345 induces apoptosis in pancreatic cancer cells through potentiation of caspase-dependent and -independent pathways. British Journal of Cancer. 113(4). 660–668. 56 indexed citations

20.

Musiyenko, Alla, Joel Andrews, Gudrun Urban, et al.. (2013). Suppression of Ser/Thr Phosphatase 4 (PP4C/ PPP4C ) Mimics a Novel Post-Mitotic Action of Fostriecin, Producing Mitotic Slippage Followed by Tetraploid Cell Death. Molecular Cancer Research. 11(8). 845–855. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact